Longitudinal Associations Between Cardiometabolic Risk Markers and Cognitive Function in Middle‐Aged and Older Adults: A Population‐Based Cohort Study
International Journal of Geriatric Psychiatry · 2026-06 · 41 (6)
DOI: 10.1002/gps.70225 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Geriatric Psychiatry, online erschienen am 30.05.2026. Verfasst von Sooyeun Choi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food and Nutrition, Kyung Hee University, Seoul, South Korea. Hauptthemen laut MEDLINE: Cardiometabolic Risk Factors, Cognition, Cardiovascular Diseases. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and ICT, South Korea.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Objectives
Dementia and cardiometabolic diseases are both characterized by long prodromal phases, which may complicate the assessment of their temporal relationships. Associations between cardiometabolic risk markers and cognition remain inconsistent. We examined the associations between cardiometabolic risk markers and cognitive function in middle‐aged and older adults.
Methods
A longitudinal analysis was conducted using data from a population‐based cohort (2007–2014) of 1255 cognitively normal Koreans aged ≥ 50 years at baseline. Cardiometabolic risk markers and Korean Mini‐Mental State Examination (K‐MMSE) scores were repeatedly assessed through health examinations and interviewer‐administered questionnaires. Multivariable linear regression (LR) and generalized estimating equation (GEE) models were used to investigate the associations between cardiometabolic risk markers and K‐MMSE scores.
Results
After full adjustment for covariates, increases in the homeostasis model assessment of insulin resistance (HOMA‐IR) and fasting insulin levels were associated with larger percent declines in K‐MMSE scores and with lower K‐MMSE scores in LR and GEE models (log‐transformed HOMA‐IR: β = −1.03, 95% CI: −1.87 to −0.20 for LR; β = −0.25, 95% CI: −0.41 to −0.08 for GEE). By age group, increases in HOMA‐IR and blood pressure were associated with declines in K‐MMSE scores among adults aged ≤ 65 years. By cognitive domain, increases in blood pressure were associated with declines in memory, while increases in HOMA‐IR were marginally associated with declines in visuospatial ability ( p = 0.052). High‐density and low‐density lipoprotein cholesterol levels were not significantly associated with cognitive function across all analyses.
Conclusions
Our findings suggest that longitudinal increases in insulin resistance and blood pressure are associated with cognitive decline, particularly among middle‐aged adults (≤ 65 years), and may differentially influence cognitive domains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food and Nutrition, Kyung Hee University, Seoul, South Korea.
- Department of Applied Statistics, Yonsei University, Seoul, South Korea.
ORCID-Profile: Sooyeun Choi
Förderung
- Ministry of Science and ICT, South Korea
Zitieren
APA
Choi, S., Park, T., & Je, Y. (2026). Longitudinal Associations Between Cardiometabolic Risk Markers and Cognitive Function in Middle‐Aged and Older Adults: A Population‐Based Cohort Study. International Journal of Geriatric Psychiatry, 41(6). https://doi.org/10.1002/gps.70225
Vancouver
Choi S, Park T, Je Y. Longitudinal Associations Between Cardiometabolic Risk Markers and Cognitive Function in Middle‐Aged and Older Adults: A Population‐Based Cohort Study. International Journal of Geriatric Psychiatry. 2026;41(6). doi:10.1002/gps.70225
BibTeX
@article{Choi2026,
author = {Choi, Sooyeun and Park, Taeyoung and Je, Youjin},
title = {Longitudinal Associations Between Cardiometabolic Risk Markers and Cognitive Function in Middle‐Aged and Older Adults: A Population‐Based Cohort Study},
journal = {International Journal of Geriatric Psychiatry},
year = {2026},
volume = {41},
number = {6},
doi = {10.1002/gps.70225}
}
EUVIMED